Literature DB >> 27384942

Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.

Thomas E Yankeelov1, Gary An2, Oliver Saut3, E Georg Luebeck4, Aleksander S Popel5, Benjamin Ribba6, Paolo Vicini7, Xiaobo Zhou8, Jared A Weis9, Kaiming Ye10, Guy M Genin11.   

Abstract

Hierarchical processes spanning several orders of magnitude of both space and time underlie nearly all cancers. Multi-scale statistical, mathematical, and computational modeling methods are central to designing, implementing and assessing treatment strategies that account for these hierarchies. The basic science underlying these modeling efforts is maturing into a new discipline that is close to influencing and facilitating clinical successes. The purpose of this review is to capture the state-of-the-art as well as the key barriers to success for multi-scale modeling in clinical oncology. We begin with a summary of the long-envisioned promise of multi-scale modeling in clinical oncology, including the synthesis of disparate data types into models that reveal underlying mechanisms and allow for experimental testing of hypotheses. We then evaluate the mathematical techniques employed most widely and present several examples illustrating their application as well as the current gap between pre-clinical and clinical applications. We conclude with a discussion of what we view to be the key challenges and opportunities for multi-scale modeling in clinical oncology.

Entities:  

Keywords:  Agent-based modeling; Cancer; Cancer screening; Computational modeling; Epidemiology; Mathematical modeling; Numerical modeling; Predictive oncology

Mesh:

Year:  2016        PMID: 27384942      PMCID: PMC4983505          DOI: 10.1007/s10439-016-1691-6

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  89 in total

Review 1.  Covariate pharmacokinetic model building in oncology and its potential clinical relevance.

Authors:  Markus Joerger
Journal:  AAPS J       Date:  2012-01-25       Impact factor: 4.009

2.  A data-driven computational model of the ErbB receptor signaling network.

Authors:  Birgit Schoeberl; Emily Pace; Shavonne Howard; Viara Garantcharova; Art Kudla; Peter K Sorger; Ulrik B Nielsen
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2006

3.  Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis.

Authors:  Birgit Schoeberl; Emily A Pace; Jonathan B Fitzgerald; Brian D Harms; Lihui Xu; Lin Nie; Bryan Linggi; Ashish Kalra; Violette Paragas; Raghida Bukhalid; Viara Grantcharova; Neeraj Kohli; Kip A West; Magdalena Leszczyniecka; Michael J Feldhaus; Arthur J Kudla; Ulrik B Nielsen
Journal:  Sci Signal       Date:  2009-06-30       Impact factor: 8.192

Review 4.  The physics of cancer: the role of physical interactions and mechanical forces in metastasis.

Authors:  Denis Wirtz; Konstantinos Konstantopoulos; Peter C Searson
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

Review 5.  Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.

Authors:  K Venkatakrishnan; L E Friberg; D Ouellet; J T Mettetal; A Stein; I F Trocóniz; R Bruno; N Mehrotra; J Gobburu; D R Mould
Journal:  Clin Pharmacol Ther       Date:  2014-12-09       Impact factor: 6.875

Review 6.  Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.

Authors:  Brett E Houk; Carlo L Bello; Bill Poland; Lee S Rosen; George D Demetri; Robert J Motzer
Journal:  Cancer Chemother Pharmacol       Date:  2009-12-05       Impact factor: 3.333

Review 7.  Fundamentals of population pharmacokinetic modelling: validation methods.

Authors:  Catherine M T Sherwin; Tony K L Kiang; Michael G Spigarelli; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

8.  Drug inhibition profile prediction for NFκB pathway in multiple myeloma.

Authors:  Huiming Peng; Jianguo Wen; Hongwei Li; Jeff Chang; Xiaobo Zhou
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

9.  Machines first, humans second: on the importance of algorithmic interpretation of open chemistry data.

Authors:  Alex M Clark; Antony J Williams; Sean Ekins
Journal:  J Cheminform       Date:  2015-03-22       Impact factor: 5.514

Review 10.  Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles.

Authors:  Jing Tang; Tero Aittokallio
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more
  21 in total

Review 1.  How and why to build a mathematical model: A case study using prion aggregation.

Authors:  Mikahl Banwarth-Kuhn; Suzanne Sindi
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

Review 2.  Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment.

Authors:  Guoyou Huang; Fei Li; Xin Zhao; Yufei Ma; Yuhui Li; Min Lin; Guorui Jin; Tian Jian Lu; Guy M Genin; Feng Xu
Journal:  Chem Rev       Date:  2017-10-09       Impact factor: 60.622

3.  Introduction to Mathematical Oncology.

Authors:  Russell C Rockne; Jacob G Scott
Journal:  JCO Clin Cancer Inform       Date:  2019-04

4.  Multi-scale models of lung fibrosis.

Authors:  Julie Leonard-Duke; Stephanie Evans; Riley T Hannan; Thomas H Barker; Jason H T Bates; Catherine A Bonham; Bethany B Moore; Denise E Kirschner; Shayn M Peirce
Journal:  Matrix Biol       Date:  2020-05-11       Impact factor: 11.583

5.  A HYBRID THREE-SCALE MODEL OF TUMOR GROWTH.

Authors:  H L Rocha; R C Almeida; E A B F Lima; A C M Resende; J T Oden; T E Yankeelov
Journal:  Math Models Methods Appl Sci       Date:  2017-11-24       Impact factor: 3.817

6.  A Coupled Mass Transport and Deformation Theory of Multi-constituent Tumor Growth.

Authors:  Danial Faghihi; Xinzeng Feng; Ernesto A B F Lima; J Tinsley Oden; Thomas E Yankeelov
Journal:  J Mech Phys Solids       Date:  2020-03-14       Impact factor: 5.471

7.  Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.

Authors:  Thomas D Gaddy; Qianhui Wu; Alyssa D Arnheim; Stacey D Finley
Journal:  PLoS Comput Biol       Date:  2017-12-21       Impact factor: 4.475

Review 8.  Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer.

Authors:  Matthew T McKenna; Jared A Weis; Amy Brock; Vito Quaranta; Thomas E Yankeelov
Journal:  Transl Oncol       Date:  2018-04-16       Impact factor: 4.243

9.  In silico mouse study identifies tumour growth kinetics as biomarkers for the outcome of anti-angiogenic treatment.

Authors:  Qianhui Wu; Alyssa D Arnheim; Stacey D Finley
Journal:  J R Soc Interface       Date:  2018-08       Impact factor: 4.118

10.  Calibration of Multi-Parameter Models of Avascular Tumor Growth Using Time Resolved Microscopy Data.

Authors:  E A B F Lima; N Ghousifam; A Ozkan; J T Oden; A Shahmoradi; M N Rylander; B Wohlmuth; T E Yankeelov
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.